ARTHROPLASTY
Similar efficacy with EACA and TXA for reduction of blood loss in patients undergoing TKA
J Orthop Traumatol. 2019 Jul 18;20(1):28.3 studies (1691 patients) were included in this meta-analysis comparing EACA and TXA for the reduction of blood loss and transfusion requirement in total knee arthroplasty. The primary outcome of interest was blood loss and the amount of transfusion required. Secondary outcomes of interest included operative time, tourniquet time and complications. No significant differences were observed in all outcomes between the EACA and TXA groups.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
